Trump makes announcement on weight loss drug prices
Digest more
2don MSN
This next-gen weight-loss drug offers a new hope — and a bonus Ozempic and Wegovy don’t have
Eli Lilly and Company announced promising results for its next-generation weight-loss drug Thursday, with patients losing up to 20.1 percent of their body weight on eloralintide.
Pfizer and Novo Nordisk are locked in a bidding war for biotech firm Metsera as the pharmaceutical giants seek to augment their pipeline in the booming weight-loss drug market.